You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: TERBUTALINE SULFATE


✉ Email this page to a colleague

« Back to Dashboard


TERBUTALINE SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Areva Pharms TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 200122 ANDA Areva Pharmaceuticals 59923-615-05 5 VIAL, SINGLE-USE in 1 CARTON (59923-615-05) / 1 mL in 1 VIAL, SINGLE-USE (59923-615-01) 2024-10-04
Fresenius Kabi Usa TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076887 ANDA Henry Schein, Inc. 0404-9962-01 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL 2022-01-12
Fresenius Kabi Usa TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076887 ANDA Fresenius Kabi USA, LLC 63323-665-01 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) 2011-03-10
Hikma Farmaceutica TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078630 ANDA Hikma Pharmaceuticals USA Inc. 0143-9375-10 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) 2009-05-20
Hikma Farmaceutica TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078630 ANDA Hikma Pharmaceuticals USA Inc. 0143-9746-10 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) 2009-05-20
Hikma Farmaceutica TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078630 ANDA Henry Schein, Inc. 0404-9778-01 1 VIAL in 1 BAG (0404-9778-01) / 1 mL in 1 VIAL 2025-10-07
Hikma Farmaceutica TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078630 ANDA Medical Purchasing Solutions. LLC 71872-7080-1 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL 2009-05-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Terbutaline Sulfate

Last updated: July 29, 2025

Introduction

Terbutaline sulfate is a bronchodilator widely used to manage asthma and other respiratory conditions. As a beta-2 adrenergic receptor agonist, it relaxes bronchial smooth muscle, providing relief from bronchospasm. Its application spans clinical settings, with consistent demand driven by respiratory disease prevalence. Ensuring a reliable supply chain for terbutaline sulfate is critical for manufacturers, healthcare providers, and regulatory authorities. This comprehensive review maps the key suppliers, evaluates their market positions, and highlights strategic considerations in sourcing this pharmaceutical compound.

Market Overview of Terbutaline Sulfate

The global pharmaceutical landscape for terbutaline sulfate primarily involves manufacturing entities based in India, China, and European regions. The compound's synthesis complexity is moderate, primarily involving chemical synthesis routes that necessitate high purity standards per pharmacopoeial requirements. The drug's broad use as an inhalation solution, injectable, and oral tablets enhances supplier diversity but also imposes stringent quality and regulatory compliance standards.

Market drivers include the rising prevalence of asthma and COPD globally[1], alongside expanding applications in veterinary medicine. The competitive landscape is characterized by a mix of multinational pharmaceutical firms, generic manufacturers, and contract manufacturing organizations (CMOs).

Key Suppliers of Terbutaline Sulfate

1. Indian Pharmaceutical Manufacturers

A. Cipla Ltd.

Cipla is among the foremost producers of terbutaline sulfate, with extensive manufacturing capabilities validated by stringent GMP standards. Cipla provides active pharmaceutical ingredients (APIs) to global markets and adheres to international regulatory compliances, including U.S. FDA and EMA approvals for certain products[2].

B. Laurus Labs

Laurus Labs specializes in APIs, including terbutaline sulfate. The company has established a supply chain validated through rigorous quality management systems. Laurus supplies APIs to generic pharmaceutical companies worldwide, emphasizing cost-efficiency without compromising on quality[3].

C. Aurobindo Pharma

Aurobindo's API division produces terbutaline sulfate with high purity standards. Their API manufacturing facilities are NABL and USFDA certified, enabling export to regulated markets. They are known for their vertically integrated supply chain, ensuring consistency and scalability[4].

2. Chinese API Manufacturers

A. Zhejiang Xianquan Pharmaceutical Co., Ltd.

This company manufactures terbutaline sulfate API primarily for Asian markets. They possess GMP-certified facilities and supply to both generic and branded manufacturers. Their competitive pricing offers strategic advantages in price-sensitive markets[5].

B. Shandong Xinhua Pharmaceutical Co.

Shandong Xinhua has a diversified portfolio of respiratory APIs, with terbutaline sulfate as a key product. The company emphasizes quality control, with certifications aligning with international standards. Their global distribution network supports export opportunities[6].

3. European and North American Suppliers

While fewer in number, certain European and North American firms, including BASF and Lonza, supply specialized batches or custom synthesis services for terbutaline sulfate, primarily targeting high-end pharmaceutical clients. Their offerings focus on high purity, regulatory compliance, and GMP validation.

4. Contract Manufacturing Organizations (CMOs) and Traders

Several CMOs globally provide custom synthesis and bulk procurement services for terbutaline sulfate. These include firms in India, China, and Eastern Europe, often offering flexible supply options tailored to client specifications.

Supply Chain and Regulatory Considerations

  • Quality Standards: Suppliers must comply with Good Manufacturing Practices (GMP) and meet pharmacopoeial specifications (USP, EP, JP).

  • Regulatory Approvals: Suppliers with certifications from FDA, EMA, and other regulators tend to have a competitive advantage, especially in regulated markets.

  • Pricing and Lead Times: Cost-effective suppliers with reliable lead times are preferred, particularly amid supply chain disruptions.

  • Capacity and Scalability: Suppliers with scalable manufacturing can better fulfill large or sudden order volumes.

Emerging Trends and Strategic Sourcing

The shift toward stricter regulatory standards and globalized supply chains increases dependence on Asian manufacturers, particularly from India and China. Diversification of sources is advisable for risk mitigation. Additionally, advancements in sustainable manufacturing practices and quality assurance are influencing supplier selection processes.

Conclusion

A resilient supply chain for terbutaline sulfate hinges on selecting suppliers that balance quality, cost, and regulatory compliance. Indian and Chinese manufacturers dominate the market, offering extensive capacity and competitive pricing. Nevertheless, partnerships with European and North American firms can augment supply security for high-regulatory-standard markets. Vigilant monitoring of regulatory statuses, quality certifications, and capacity planning are essential for sustained procurement success.

Key Takeaways

  • Indian and Chinese manufacturers lead global supplies of terbutaline sulfate, with established GMP certifications.
  • Quality assurance, regulatory compliance, and capacity scalability are critical factors in supplier selection.
  • Diversification across multiple geographic regions reduces supply chain risks amid geopolitical and logistical challenges.
  • Strategic sourcing should consider ongoing regulatory changes and industry standards.
  • Contract manufacturing organizations provide flexible, scalable options beneficial for large or fluctuating demand.

FAQs

1. What are the primary factors influencing the selection of suppliers for terbutaline sulfate?
Quality standards (GMP compliance), regulatory certifications (FDA, EMA), capacity, cost, delivery timelines, and supplier reputation are key criteria.

2. Are there synthetic routes that impact the choice of supplier?
Yes. Suppliers employing high-purity, environmentally sustainable synthesis methods aligned with Good Manufacturing Practices (GMP) are preferred, especially for regulated markets.

3. How does geopolitics affect the supply of terbutaline sulfate?
Trade restrictions, tariffs, and geopolitical tensions can influence procurement, making diversification across multiple suppliers and regions advisable.

4. Can small pharmaceutical companies access terbutaline sulfate from global suppliers?
Yes. Many Indian and Chinese API manufacturers supply in various batch sizes, catering to both large-scale and small-scale pharmaceutical entities.

5. What future trends could impact the supplier landscape for terbutaline sulfate?
Growing regulatory harmonization, increased quality standards, and technological innovations in synthesis and quality control are shaping the supplier ecosystem.

Sources

[1] Global Asthma Report 2022, Global Initiative for Asthma.
[2] Cipla Ltd., Annual Report 2022.
[3] Laurus Labs, Corporate Presentation 2022.
[4] Aurobindo Pharma, Annual Report 2022.
[5] Zhejiang Xianquan Pharmaceutical Co., Ltd., Company Website.
[6] Shandong Xinhua Pharmaceutical Co., Ltd., Product Brochure.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing